Back to Resource Center

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention

December 2015

Click to view Press Release

Click for full info +

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention
01 December 2015
click to view Press Release
In this Press Release:
Health Risk(s):

  • HIV
    • Product Type(s):

  • Microbicides
    • Topic(s):

  • Product Development


    • Full Info:


    Resource Type:

    Press Release

    Citation:

    (2015, December 1). International Partnership for Microbicides. 

    Authors:

    [No authors listed]

    Health Risks(s):

    • HIV

    Product type(s):

    • Microbicide

    Topic(s):

    • Development

        URL of resource:

        http://ipmglobal.org/publications/ipm-receives-license-janssen-develop-fda-approved-hiv-1-drug-microbicide-hiv-prevention

        Back to Resource Center